Diabetes pill shows promise in Real-World saudi study
NCT ID NCT05230589
Summary
This study observed how well the oral medication Rybelsus (semaglutide) works for people with type 2 diabetes in everyday life in Saudi Arabia. Researchers followed 194 adults for 8-10 months to see if the pill helped lower blood sugar and body weight. The goal was to collect real-world information on the medication's effectiveness and how satisfied patients were with their treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre for Saudi
Riyadh, 3542, Saudi Arabia
-
Specialized Medical Cente
Riyadh, Saudi Arabia
Conditions
Explore the condition pages connected to this study.